Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dynavax Technologies Corp (NASDAQ:DVAX)

14.78
Delayed Data
As of Jul 26
 -0.22 / -1.47%
Today’s Change
12.84
Today|||52-Week Range
32.49
-38.82%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close15.00
Today’s open14.92
Day’s range14.70 - 15.14
Volume323,885
Average volume (3 months)720,696
Market cap$577.4M
Dividend yield--
Data as of 3:59pm ET, 07/26/2016

Growth & Valuation

Earnings growth (last year)+5.80%
Earnings growth (this year)+10.69%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.29%
P/E ratioNM
Price/Sales196.15
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
PDLIPDL BioPharma Inc+0.05+1.44%
EPZMEpizyme Inc+0.02+0.20%
HRTXHeron Therapeutics I...+0.09+0.54%
ZIOPZIOPHARM Oncology In...+0.17+3.65%
Data as of 3:59pm ET, 07/26/2016

Financials

Last reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$4.1M
Annual profit (last year)-$106.8M
Net profit margin-2,636.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts

Partner Offers

Search for Jobs